Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
RBC Capital raises the target price of Vertex Pharmaceuticals to $570

RBC Capital raises the target price of Vertex Pharmaceuticals to $570

格隆汇格隆汇2026/07/08 08:26
Show original
Glonghui, July 8|RBC Capital raised the target price of Vertex Pharmaceuticals from $543 to $570, maintaining an “outperform” rating. (Glonghui)
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

VTV ETF Declines 0.2%

Dow Jones•2026/09/29 20:37
VTV ETF Declines 0.2%

VGT ETF Falls 0.2%

Dow Jones•2026/09/29 20:36
VGT ETF Falls 0.2%

IEFA ETF Declines 0.5%

Dow Jones•2026/09/29 20:35